NCT03597867View on ClinicalTrials.gov

PGE2 Levels in Patient Treated With NSAIDs

PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

July 5, 2018

Study Completion Date

July 9, 2018

Conditions
Ocular Inflammation
Interventions
OTHER

Placebo

Artificial tears for 3 days preoperatively

DRUG

Dicloftil

Dosing of drug 3 days prior to surgery

DRUG

Nevanac

Dosing of drug 3 days prior to surgery

DRUG

Indom

Dosing of drug 3 days prior to surgery

DRUG

Yellox

Dosing of drug 3 days prior to surgery

Trial Locations (1)

34129

Eye Clinic, Departement of Medical Surgical Sciences and Health, University of Trieste, Trieste

All Listed Sponsors
lead

University of Trieste

OTHER

NCT03597867 - PGE2 Levels in Patient Treated With NSAIDs | Biotech Hunter | Biotech Hunter